Answers are grounded in this paper and cite their sources.
This review outlines the history of vancomycin and other key glycopeptide antibiotics and the molecular basis of vancomycin resistance, and focuses on the development of synthetic inhibitors of vancomycin-resistant enzymes VanR, S, A, H and X to overcome resistance. The literature up to July 2001 is reviewed and 119 references are cited.
No takes yet. Share an insight, caveat, or question.
Yong Gao (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: